Abstract:Changes of bone turnover with aging are responsible for bone loss and play a major role in osteoporosis. Although an increase of bone turnover has been documented at the time of menopause, the subsequent abnormalities of bone resorption and formation and their potential role in determining bone mass in the elderly have not been investigated. To address this issue, we have measured a battery of new sensitive and specific markers of bone turnover in a population-based study of 653 healthy women analyzed cross-sectionally, including 432 women postmenopausal from 1 to 40 years, and the data were correlated with bone mineral density (BMD) measured by dual-energy X-ray absorptiometry (DXA) at different skeletal sites. Bone formation was assessed by serum osteocalcin (OC), serum bone-specific alkaline phosphatase (B-ALP), serum C-propeptide of type I collagen (PICP), and bone resorption by the urinary excretion of two pyridinoline cross-linked peptides (NTX and CTX). Bone turnover increased in perimenopausal women with both irregular menses and elevated serum follicle stimulating hormone (FSH). Menopause induced a 37-52% and 79-97% increase in the bone formation and bone resorption marker levels, respectively (p < 0.0001 except for PICP). In postmenopausal women, bone formation markers did not decrease with age. When resorption markers were corrected by whole body bone mineral content (BMC), the fraction of bone resorbed per day was not correlated with age in postmenopausal women and remained elevated for up to 40 years after menopause. In premenopausal women, the bone turnover rate accounted for only 0-10% of the variation in whole body BMC, total hip, distal radius, and lumbar spine BMD. With increasing time after menopause, the importance of the bone turnover rate as a determinant of bone mass increased at all sites and accounted for up to 52% of the BMD variance in elderly women. Thus, in women 20 years or more postmenopause, bone turnover was higher in those in the lowest quartile than in those in the highest quartile of BMD. In elderly women, 20 years since menopause and over, but not in younger ones, serum PTH was negatively correlated with serum 25-hydroxyvitamin D (r = -0.22, p < 0.05) and explained only 5-8% of the bone turnover variance (p < 0.01-0.001). These data indicate that the overall rates of both bone formation and bone resorption remain high in elderly women. The rate of bone turnover appears to play an increasing role as a determinant of bone mass with increasing time since menopause with a high bone turnover rate being associated with a low bone mass. Thus assessing bone marker levels may be useful in the evaluation of osteoporosis risk. In elderly women, secondary hyperparathyroidism caused in part by reduced serum 25-hydroxyvitamin D appears to be a marginal determinant of an increased bone turnover rate.

Quantifying the Balance Between Total Bone Formation and Total Bone Resorption: An Index of Net Bone Formation

New bone turnover measure is more accurate predictor of postmenopausal bone loss.

Urinary N-telopeptide and Rate of Bone Loss Over the Menopause Transition and Early Postmenopause

Biochemical markers of bone turnover in lactating and nonlactating postpartum women

The Relationship Between Bone Turnover Markers and BMD Decreasing Rates in Chinese Middle-Aged Women.

Systemic Inflammation Markers Associated with Bone Mineral Density in Perimenopausal and Postmenopausal Women

Increase in C-Reactive Protein Predicts Increase in Rate of Bone Mineral Density Loss: The Study of Women's Health Across the Nation

Changes in bone resorption across the menopause transition: effects of reproductive hormones, body size, and ethnicity

[The Relationships Between Biomarkers of Age-Related Changes in Bone Turnover and Bone Mineral Density in Healthy Chinese Women].

Characteristics of Long‐Term Femoral Neck Bone Loss in Postmenopausal Women: A 25‐Year Follow‐Up

Physical Activity and Bone Turnover Markers: A Cross-Sectional and a Longitudinal Study

Exploring the Relationship of Bone Turnover Markers and Bone Mineral Density in Community-Dwelling Postmenopausal Women

The relationships between bone turnover markers and bone mineral density and risk for osteoporosis in middle-aged and older women

Perimenopausal bone histomorphometry before and after menopause

Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: Results from the Study of Women's Health Across the Nation (SWAN)

Bone turnover markers during lactation, postpartum amenorrhea and resumption of menses

Association between bile acid metabolism and bone mineral density in postmenopausal women.

Relationship of transforming growth factor beta 1 with bone turnover markers and bone mineral density

Age-related changes in bone biochemical markers and their relationship with bone mineral density in normal Chinese women

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis

[Prospective Investigation of Annual Bone Loss Rate in Females in Changsha City, Hunan Province].